Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 04 - 13 save search
Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
NVCR | $12.35 2.45% 2.39% 1.1M
|
Health Technology
|
| O: 50.14%
H: 10.14%
C: -0.34%
lung cancer cancer phase 3 trial dmc recommendations decades
Longeveron Announces Positive Results of Phase I Clinical Study of Lomecel-B Cell Therapy for Alzheimer’s Disease
Published: 2021-04-13 (Crawled : 15:00) - biospace.com/
LGVN 4 d | $1.73 -4.95% -5.2% 300K
|
|
| O: 32.23%
H: 2.4%
C: -20.0%
disease alzheimer positive results positive therapy results lomecel-b alzheimer’s alzheimer's disease t-cell alzheimer's
Zai Lab Partner Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
Published: 2021-04-13 (Crawled : 12:00) - globenewswire.com
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: 13.59%
H: 7.76%
C: 7.53%
NVCR | $12.35 2.45% 2.39% 1.1M
|
Health Technology
|
| O: 50.14%
H: 10.14%
C: -0.34%
lung cancer cancer phase 3 trial
Positive Topline Data Shows Fostamatinib Meets Primary Endpoint of Safety in Phase 2 Clinical Trial in Hospitalized Patients with COVID-19
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.35%
H: 1.36%
C: 0.75%
RIGL | $1.125 -1.32% -1.33% 6.4M
|
Health Technology
|
| O: 13.27%
H: 5.14%
C: 3.14%
covid phase 2 positive topline trial
vTv Therapeutics Receives FDA Breakthrough Therapy Designation for TTP399 for the Treatment of Type 1 Diabetes
Published: 2021-04-13 (Crawled : 12:00) - globenewswire.com
VTVT | $25.39 1.66% 1.63% 4.2K
|
Health Technology
|
| O: 10.89%
H: 32.98%
C: 20.7%
diabetes treatment fda therapy ttp399 breakthrough therapy designation
Biomica Announces Positive Pre-Clinical Results, Demonstrating Efficacy of BMC128 in Melanoma
Published: 2021-04-13 (Crawled : 13:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 10.57%
H: 1.98%
C: -6.26%
pre-clinical positive results preclinical
Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
Published: 2021-04-12 (Crawled : 00:00) - fda.gov
SUPN | $30.26 1.04% 1.02% 200K
|
Health Technology
|
| O: 6.58%
H: 5.4%
C: 4.96%
drug food
Hallmark Financial Announces Intent to Pursue IPO of its Specialty Commercial Business
Published: 2021-04-13 (Crawled : 23:00) - globenewswire.com
HALL | $0.65 34.08% 1.2K
|
Finance
|
| O: 6.5%
H: 0.25%
C: -2.54%
commercialization
INTRUSION Q1 2021 Results Surpass Expectations
Published: 2021-04-13 (Crawled : 13:15) - globenewswire.com
INTZ 4 | $1.79 0.0% 130K
|
Electronic Technology
|
| O: 5.53%
H: 15.05%
C: 12.95%
results
Lion Announces Completion of Acquisition of Lion FinTech Group
Published: 2021-04-13 (Crawled : 12:00) - prnewswire.com
LGHL | $0.5908 -7.69% -8.33% 500K
|
Technology Services
|
| O: 5.45%
H: 5.85%
C: 4.91%
acquisition
Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day
Published: 2021-04-13 (Crawled : 22:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 5.31%
H: 3.62%
C: 1.98%
covid vaccine
Socialyte joins IZEA Talent Partner Program
Published: 2021-04-13 (Crawled : 14:00) - izea.com
IZEA P | $2.565 4.27% 4.09% 56K
|
Technology Services
|
| O: 4.69%
H: 0.0%
C: -15.95%
program
IZEA Q2 2021 Managed Services Bookings Already Exceed All of Q2 2020
Published: 2021-04-13 (Crawled : 15:15) - globenewswire.com
IZEA P | $2.565 4.27% 4.09% 56K
|
Technology Services
|
| O: 4.69%
H: 0.0%
C: -15.95%
Identiv Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock and Closing of Public Offering
Published: 2021-04-12 (Crawled : 00:00) - globenewswire.com
INVE 4 | $5.11 1.59% 1.57% 64K
|
Electronic Technology
|
| O: 4.52%
H: 10.86%
C: 8.98%
offering
Axcella Announces AXA1125’s IND Clearance for the Treatment of NASH
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 4.26%
H: 8.62%
C: 5.67%
treatment nash clearance
Nemaura Medical Launches BEAT®diabetes Smartphone App on Android and iOS Platforms; Begins Pilot Distribution of proBEAT™ Sensors
Published: 2021-04-13 (Crawled : 12:15) - globenewswire.com
NMRD | $0.06 -28.78% 120K
|
Health Technology
|
| O: 3.62%
H: 1.54%
C: -7.29%
diabetes sensor distribution
Handy Announces Partnership with Savvy
Published: 2021-04-13 (Crawled : 04:00) - prnewswire.com
ANGI | $2.06 -1.44% -1.46% 590K
|
Technology Services
|
| O: 3.26%
H: 11.76%
C: 8.51%
partnership
First Skip being tipped at Central Shaft
Published: 2021-04-13 (Crawled : 15:00) - caledoniamining.com
CMCL | $10.03 -0.99% 0.0% 92K
|
Non-Energy Minerals
|
| O: 3.2%
H: 2.67%
C: 1.22%
Fortuna releases 2020 Sustainability Report
Published: 2021-04-12 (Crawled : 00:00) - globenewswire.com
FSM | News | $4.64 -0.43% -1.49% 3.7M
|
Non-Energy Minerals
|
| O: 2.93%
H: 2.17%
C: 0.95%
report
TFF Pharmaceuticals Awarded Contract under DARPA’s Next-Generation Personalized Protective Biosystems Program for U.S. Warfighters
Published: 2021-04-13 (Crawled : 15:00) - biospace.com/
TFFP | $3.04 2.36% 2.3% 13K
|
Health Technology
|
| O: 2.81%
H: 2.49%
C: 1.69%
contract program awards
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.